Delink antibiotic revenue from sales volume through subscription payments
#00391
Pay suppliers predictable amounts for the availability and public-health value of priority antibiotics rather than rewarding the number of doses sold.
England, United Kingdom
OngoingNHS England and the National Institute for Health and Care Excellence · National
NHS England and NICE piloted fixed annual payments for access to cefiderocol and ceftazidime-avibactam, with value assessment designed to recognize preparedness and public-health benefits rather than prescription volume…
Antimicrobial products in the initial pilot2products
2 sources